Severe Compressive Ulnar Nerve Neuropathy (McGowan Grade III)
Conditions
Brief summary
Ulnar nerve compression at the elbow is a common problem and can significantly affect hand function in severe cases. The current, standard treatment is Ulnar nerve decompression with or without transposition (moving the ulnar nerve to a site where there is less compression). In severe compression, the clinical results after this surgery are typically poor. Distal transfers of functioning nerves (at the level of the wrist) to the compressed ulnar nerve (anterior interosseous nerve to ulnar motor fascicles) have been suggested to supercharge or augment hand muscles while nerve axons regenerate from the level of the elbow after decompression/transposition. In fact, this treatment is becoming widely adopted without clear evidence that it changes outcomes. The investigators propose to prospectively compare the effectiveness of ulnar nerve decompression/transposition versus decompression/transposition and distal nerve transfer.
Detailed description
The purpose of this study is to prospectively compare the outcomes of patients with severe (intrinsic hand muscle dysfunction) compressive ulnar neuropathy at the elbow treated with ulnar nerve decompression and subcutaneous transposition alone versus ulnar nerve decompression with subcutaneous transposition and AIN to ulnar nerve reverse end-to-side transfer. The study objectives of this project are the following: 1. To prospectively compare the clinical outcomes of patients with severe ulnar neuropathy at the elbow who receive ulnar nerve decompression with subcutaneous transposition and AIN to ulnar motor reverse end-to-side nerve transfer versus decompression and subcutaneous transposition alone. 2. To prospectively compare the electrophysiologic outcomes (nerve conduction studies and EMG) of patients with severe ulnar neuropathy at the elbow who receive ulnar nerve decompression with subcutaneous transposition and AIN to ulnar motor reverse end-to-side nerve transfer versus decompression and subcutaneous transposition alone.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients (greater than 18 years) with severe compressive ulnar nerve neuropathy (McGowan grade III) at the elbow who consent to either ulnar nerve decompression with transposition alone or ulnar nerve decompression with transposition plus nerve transfer.
Exclusion criteria
* Patients under the age of 18 and over 70. * Patients with ulnar neuropathy at multiple anatomic locations along the course of the nerve. * Patients with mild to moderate ulnar neuropathy (McGowan grade I and II).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain scores on the numeric pain rating scale | one year | The patient-rated ulnar nerve evaluation (PRUNE) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| evaluation of reinnvervation of hand intrinsic muscles | one year | Electromyography (EMG) |
| functional performance assessment on the numeric scale | one year | The patient-rated ulnar nerve evaluation (PRUNE); Michigan hand outcome questionnaire |